Anand Rayons Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 11, 2025, 3:45 pm

Competitors of Anand Rayons Ltd

All Competitor Stocks of Anand Rayons Ltd

Quarterly Result

Last Updated: August 19, 2025, 11:45 pm

Below is a detailed analysis of the quarterly data for Anand Rayons Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 75.95 Cr.. The value appears to be declining and may need further review. It has decreased from 85.85 Cr. (Mar 2025) to 75.95 Cr., marking a decrease of 9.90 Cr..
• For Expenses, as of Jun 2025, the value is 74.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 83.01 Cr. (Mar 2025) to 74.82 Cr., marking a decrease of 8.19 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.13 Cr.. The value appears to be declining and may need further review. It has decreased from 2.84 Cr. (Mar 2025) to 1.13 Cr., marking a decrease of 1.71 Cr..
• For OPM %, as of Jun 2025, the value is 1.49%. The value appears to be declining and may need further review. It has decreased from 3.31% (Mar 2025) to 1.49%, marking a decrease of 1.82%.
• For Other Income, as of Jun 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from 0.09 Cr. (Mar 2025) to 0.31 Cr., marking an increase of 0.22 Cr..
• For Interest, as of Jun 2025, the value is 0.18 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.60 Cr. (Mar 2025) to 0.18 Cr., marking a decrease of 0.42 Cr..
• For Depreciation, as of Jun 2025, the value is 0.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.17 Cr.. The value appears to be declining and may need further review. It has decreased from 2.25 Cr. (Mar 2025) to 1.17 Cr., marking a decrease of 1.08 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is 1.18 Cr.. The value appears to be declining and may need further review. It has decreased from 2.25 Cr. (Mar 2025) to 1.18 Cr., marking a decrease of 1.07 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.56. The value appears to be declining and may need further review. It has decreased from 1.22 (Mar 2025) to 0.56, marking a decrease of 0.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:57 am

Growth

Last Updated: September 5, 2025, 2:16 pm

Balance Sheet

Last Updated: July 25, 2025, 1:53 pm

Below is a detailed analysis of the balance sheet data for Anand Rayons Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 37.00 Cr..
• For Borrowings, as of Mar 2025, the value is 16.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 29.00 Cr. (Mar 2024) to 16.00 Cr., marking a decrease of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing). It has decreased from 9.00 Cr. (Mar 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 99.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 25.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 98.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2024) to 98.00 Cr., marking an increase of 25.00 Cr..
• For Total Assets, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 25.00 Cr..

Notably, the Reserves (58.00 Cr.) exceed the Borrowings (16.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Anand Rayons Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has decreased from 2.09 (Mar 24) to 1.89, marking a decrease of 0.20.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 2.09 (Mar 24) to 2.24, marking an increase of 0.15.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 3. It has decreased from 2.24 (Mar 24) to 2.06, marking a decrease of 0.18.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.83. It has increased from 24.19 (Mar 24) to 41.83, marking an increase of 17.64.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.83. It has increased from 24.19 (Mar 24) to 41.83, marking an increase of 17.64.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 170.68. It has decreased from 229.74 (Mar 24) to 170.68, marking a decrease of 59.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.15. This value is within the healthy range. It has decreased from 4.90 (Mar 24) to 4.15, marking a decrease of 0.75.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.98. This value is within the healthy range. It has decreased from 4.75 (Mar 24) to 3.98, marking a decrease of 0.77.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.53. This value is within the healthy range. It has decreased from 2.83 (Mar 24) to 2.53, marking a decrease of 0.30.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 2. It has decreased from 2.09 (Mar 24) to 1.89, marking a decrease of 0.20.
• For PBDIT Margin (%), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 10. It has increased from 2.13 (Mar 24) to 2.43, marking an increase of 0.30.
• For PBIT Margin (%), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 10. It has increased from 2.07 (Mar 24) to 2.32, marking an increase of 0.25.
• For PBT Margin (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 10. It has increased from 1.23 (Mar 24) to 1.48, marking an increase of 0.25.
• For Net Profit Margin (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has increased from 0.90 (Mar 24) to 1.10, marking an increase of 0.20.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.51. This value is below the healthy minimum of 15. It has decreased from 8.63 (Mar 24) to 4.51, marking a decrease of 4.12.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.03. This value is below the healthy minimum of 10. It has decreased from 17.12 (Mar 24) to 9.03, marking a decrease of 8.09.
• For Return On Assets (%), as of Mar 25, the value is 3.51. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 3.51, marking a decrease of 0.71.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.05, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.79 (Mar 24) to 0.20, marking a decrease of 0.59.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 3.62. It has decreased from 4.65 (Mar 24) to 3.62, marking a decrease of 1.03.
• For Current Ratio (X), as of Mar 25, the value is 5.36. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 24) to 5.36, marking an increase of 3.14.
• For Quick Ratio (X), as of Mar 25, the value is 4.56. This value exceeds the healthy maximum of 2. It has increased from 2.02 (Mar 24) to 4.56, marking an increase of 2.54.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 29.91. This value exceeds the healthy maximum of 8. It has decreased from 53.73 (Mar 24) to 29.91, marking a decrease of 23.82.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 3. It has increased from 2.54 (Mar 24) to 2.87, marking an increase of 0.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 3. It has increased from 2.08 (Mar 24) to 2.31, marking an increase of 0.23.
• For Enterprise Value (Cr.), as of Mar 25, the value is 360.21. It has increased from 70.91 (Mar 24) to 360.21, marking an increase of 289.30.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has increased from 0.20 (Mar 24) to 1.15, marking an increase of 0.95.
• For EV / EBITDA (X), as of Mar 25, the value is 47.23. This value exceeds the healthy maximum of 15. It has increased from 9.65 (Mar 24) to 47.23, marking an increase of 37.58.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 1.17, marking an increase of 1.01.
• For Price / BV (X), as of Mar 25, the value is 4.78. This value exceeds the healthy maximum of 3. It has increased from 1.57 (Mar 24) to 4.78, marking an increase of 3.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 1.17, marking an increase of 1.01.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness